SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,100,189 | -83.0% | 116,319 | -84.0% | 0.61% | -80.1% |
| Q2 2023 | $83,175,303 | +87.9% | 726,295 | +126.1% | 3.08% | +69.2% |
| Q1 2023 | $44,272,236 | +104.6% | 321,209 | +92.4% | 1.82% | +33.2% |
| Q4 2022 | $21,638,564 | +140.9% | 166,990 | +102.8% | 1.37% | +12.4% |
| Q4 2018 | $8,984,000 | -63.2% | 82,327 | -45.5% | 1.22% | -26.3% |
| Q3 2018 | $24,384,000 | +218.1% | 150,974 | +160.3% | 1.65% | +93.7% |
| Q2 2018 | $7,666,000 | -13.8% | 58,000 | -51.7% | 0.85% | -32.2% |
| Q1 2018 | $8,891,000 | +3.1% | 120,000 | -22.6% | 1.26% | +11.2% |
| Q4 2017 | $8,624,000 | – | 155,000 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |